Perspectives in Rheumatic Diseases Conference

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Orrin Troum, MD discusses Safety Data by the Numbers #rheumatoidarthritis #rheumatology #rheumatic #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Aarat M. Patel, MD presents on Recognizing and Diagnosing #Autoinflammatory Diseases: A Focus on Still's Disease. This session is sponsored by Novartis #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Brian F. Mandell, MD, PhD presents the latest 2020 ACR Gout Guidelines and Paradigms #Gout #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Paul D. Miller M.D., HDSc (HON) presents Treatment of Low Bone Density in CKD #BoneDensity #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Jon T. Giles, MD discusses Sorting Out Interstitial Lung Disease in the Patient with Rheumatic Disease #rheumatology #lungdisease #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Atul Deodhar, MD kicks off the final day of general sessions with a talk on The Diagnosis and Spectrum of #Spondyloarthritis #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Day two concludes with an interactive Q&A with Niels Vande Casteele, PharmD, MPH, Dinesh Khanna, MCCS, MSc, James S. Louie, MD, Andrew Mammen, MD, PhD #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

James S. Louie, MD gives a fascinating talk on The Art of #Rheumatology #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Andrew Mammen, MD, PhD presents on Myositis Antibodies – When to Order and How to Use #antibody #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Niels Vande Casteele, PharmD, MPH discusses Anti-Drug Antibodies and Slowing Drug Clearance: Maintaining Efficacy of Biologics #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Dinesh Khanna, MCCS, MSc presents on Diagnosis and Management of Early Systemic Sclerosis #sclerosis #rheumatology #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Joel A. Block, MD, Marcy A. Bolster, MD, Kathryn T. Hall, PhD host a live Q&A session with attendees #Rheum #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Marcy B. Bolster, MD discusses Bisphosphonates: Four Common Questions Asked by Patients #osteonecrosis #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Joel A. Block, MD presents his second talk of the day on Interventional Therapies for Knee OA: Game Changers vs Expensive Placebos? #Osteoarthritis #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Kathryn T. Hall, PhD discusses The Powerful Placebo: As Much in the Genes as In the Head? #Placebo #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Joel A. Block, MD presents Messages from the OA Guidelines #osteoarthritis #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Gordon K.W. Lam, MD discusses The Role of IL-6 in Inflammation, Rheumatoid Arthritis, and Cytokine Release Syndrome. This session is sponsored by Sanofi #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

John R P Tesser, MD, FACP, FACR presents A Different IL-17A Antagonist for the Treatment of Psoriatic Arthritis and Axial Spondyloarthritis. This session is sponsored by Lilly #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Day 1 of general sessions conclude with a Q&A including Leonard H. Calabrese, DO, Philip J. Mease, MD, Kevin Winthrop, MD, MPH #PRD2020

[Perspectives in Rheumatic Diseases Conference @PRDCME]

Kevin Winthrop, MD, MPH discusses Opportunistic Infections in the Immunosuppressed Patient – The Baseline Therapy Matters! #PRD2020